The University of Medicine and Dentistry of New Jersey was a state-run health sciences institution of New Jersey, United States. It was founded as the Seton Hall College of Medicine and Dentistry in 1954, and by the 1980s was both a major school of health sciences, and a major research university.

During the past decade, University of Medicine and Dentistry of New Jersey conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 8 clinical trials were completed, i.e. on average, 800% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University of Medicine and Dentistry of New Jersey" #1 sponsor was "University of Medicine and Dentistry of New Jersey" with 7 trials, followed by "Gilead Sciences" with 2 trials sponsored, "NCIC Clinical Trials Group" with 2 trials sponsored, "NSABP Foundation Inc" with 2 trials sponsored and "Yale University" with 2 trials sponsored. Other sponsors include 20 different institutions and companies that sponsored additional 30 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of Medicine and Dentistry of New Jersey" #1 collaborator was "National Institute of Neurological Disorders and Stroke (NINDS)" with 3 trials as a collaborator, "Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)" with 2 trials as a collaborator, "Penn State University" with 2 trials as a collaborator, "University of Colorado, Denver" with 2 trials as a collaborator and "University of Michigan" with 2 trials as a collaborator. Other collaborators include 18 different institutions and companies that were collaborators in the rest 24 trials.

According to Clinical.Site data, the most researched conditions in "University of Medicine and Dentistry of New Jersey" are "Breast Cancer" (4 trials), "HIV Infections" (4 trials), "Congestive Heart Failure" (2 trials), "Hypertension" (2 trials) and "Pregnancy" (2 trials). Many other conditions were trialed in "University of Medicine and Dentistry of New Jersey" in a lesser frequency.

Most popular intervention types in "University of Medicine and Dentistry of New Jersey" are "Drug" (23 trials), "Device" (7 trials), "Procedure" (5 trials), "Other" (3 trials) and "Biological" (2 trials). Other intervention types were less common.

The name of intervention was led by "Cyclophosphamide" (2 trials), "Docetaxel" (2 trials), "Placebo" (2 trials), "5-Fluorouracil" (1 trials) and "ACDF with plate" (1 trials). Other intervention names were less common.

The vast majority of trials in "University of Medicine and Dentistry of New Jersey" are 33 trials for "All" genders, 6 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "University of Medicine and Dentistry of New Jersey". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 31 completed trials in University of Medicine and Dentistry of New Jersey, 2 suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in University of Medicine and Dentistry of New Jersey, 4 "Phase 1" clinical trials were conducted, 9 "Phase 2" clinical trials and 13 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 8 trials that are defined as “Not Applicable".